MYWOT

Child safety

N/A

Confidence

0%

Trustworthiness

N/A

Confidence

0%

MALICIOUS CONTENT INDICATORS

Availability or unavailability of the flaggable/dangerous content on this website has not been fully explored by us, so you should rely on the following indicators with caution.

Nervianoms.com most likely does not offer any malicious content.

  • Siteadvisor

    Safety status

    N/A

  • SAFEBROWSING

    Safety status

    Safe

  • Phishtank

    Safety status

    N/A

Secure connection support

HTTPS

Nervianoms.com provides SSL-encrypted connection.

ADULT CONTENT INDICATORS

Availability or unavailability of the flaggable/dangerous content on this website has not been fully explored by us, so you should rely on the following indicators with caution.

Nervianoms.com most likely does not offer any adult content.

Popular pages

  • Homepage - Nerviano Medical Sciences

    Nerviano Medical Sciences Nerviano Medical Sciences $ About us Nerviano Medical Sciences S.r.l is focused on discovery and clinical development of small molecule NCEs for oncology. The company takes i...

  • Pipeline - Nerviano Medical Sciences

    Pipeline  Encorafenib Encorafenib is a small molecule inhibitor of the BRAF kinase, a key enzyme in the tyrosine kinase/MAPK signaling pathway (TK-RAS-RAF-MEK-ERK), which is often mutated and activate...

  • Research Overview - Nerviano Medical Sciences

    Research Overview   Research is the driving engine of our Company, with a longstanding experience in R&D and a proven track record of our capacity to carry out innovative research and to bring molecul...

  • News - Nerviano Medical Sciences

    News   NERVIANO, IT and BOSTON, Mass, October 12, 2023 – Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc., a wholly owned subsidiary of NMS ...

  • Publication - Nerviano Medical Sciences

    Publication Caldarelli M, Loriz L, Piazza L, Caputo G, DeAmici M, Papeo G Tetrahedron Letters (2022) 103, 153978   Stereoselective synthesis of 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives a...

  • Clinical programs - Nerviano Medical Sciences

    Clinical Programs   We are exploiting our core Discovery engine to constantly develop new molecular entities with potential for “first in class “ and “best in class”. Our projects target a broad numbe...

Open neighbouring websites list